Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Deepthi Vemuri"'
Publikováno v:
Annals of Indian Academy of Neurology, Vol 23, Iss 2, Pp 215-219 (2020)
Background: Myasthenia gravis (MG) is an autoimmune disorder with a chronic fluctuating course. The outcome measures encapsulate disease severity, functional impact at diagnosis, and objective evaluation of clinical benefit from therapeutic intervent
Externí odkaz:
https://doaj.org/article/6b1fdf36144a4ce2a22f4ae0bfacd3e5
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-12 (2021)
Abstract Background The meager physicochemical properties like low solubility and low dissolution rate of rosuvastatin calcium remain as an obstruction for formulation development. In the present work, we explore the evolution of rosuvastatin cocryst
Externí odkaz:
https://doaj.org/article/02711ea1628644d0ad3d64d04a72610b
Autor:
Nalini Mathala, Vijaya Bhaskara Rao, Venkata Deepthi Vemuri, Gollu Gowri, Nalla Swathi, Allam Sasikala
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 56:503-510
Publikováno v:
In Journal of Crystal Growth 15 August 2023 616
Publikováno v:
Turk J Pharm Sci
OBJECTIVES: Rosuvastatin calcium (RSC) is a synthetic biopharmaceutical classification system class-II drug with a low solubility but high permeability. The drug is used in hyperlipidemia management. In this study, the physicochemical properties of R
Autor:
Srinivas, Lankalapalli, Venkata Deepthi, Vemuri, V S Vinai Kumar, Tenneti, Purnachandra Reddy, Guntaka
Publikováno v:
Journal of Liposome Research. 32:293-307
Oral mucosa offers several advantages in the delivery of therapeutic molecules. It avoids presystemic metabolism, Nanoencapsulation techniques might be applied to conquer physical, chemical challenges and enhance drug penetration, formulation perform
Publikováno v:
Journal of Crystal Growth. 616:127202
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-12 (2021)
Background The meager physicochemical properties like low solubility and low dissolution rate of rosuvastatin calcium remain as an obstruction for formulation development. In the present work, we explore the evolution of rosuvastatin cocrystal, which
Autor:
venkata Deepthi Vemuri, Rekharani Kushwaha, Gollu Gowri, Nalini Mathala, Swathi Nalla, Sasikala Allam, Gurijala Lekhya
Publikováno v:
Critical Reviews in Therapeutic Drug Carrier Systems.
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 53:s522-s538